IDH3A and glioblastoma: The vast majority of GBM cases (~90%) are the IDH wild type (IDHwt), i.e., they do not harbor pathogenic mutation in the gene encoding isocitrate dehydrogenase (IDH), while around 10% of cases is IDH-mutated GBM, which is known to have a better prognosis for patients [2].